Moderna, Inc. (MRNA) Q4 2022 Earnings Results

Moderna Misses on EPS, Stock Down 6.7%

Moderna's earnings report showed a significant miss on EPS, which contributed to a 6.7% drop in stock price. The lack of revenue information and guidance may raise concerns among investors about the company's future performance. Overall, the results suggest uncertainty in the company's financial outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$3.61	N/A	-22.45%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

Moderna Misses on EPS, Stock Down 6.7%

Key numbers

Management commentary

Moderna, Inc.

More earnings this week

Moderna Misses on EPS, Stock Down 6.7%

Key numbers

Management commentary